A cleaner and multifunctional Citrus limonium-assisted ZnO/MgO nanocomposite synthesis: Extensive investigations on antibacterial, antioxidant, and antidiabetic applications
Date Issued
2024
Author(s)
S. Priyadharshini
S.J.J. Kay
M. Ayyanar
C. Jenipher
A. Thirumurugan
Abstract
Herein, an extensive study to understand the antibacterial, antioxidant, and antidiabetic activities of Citrus limonium fruit juice-mediated ZnO/MgO nanocomposite synthesis is reported. Its performances are compared with their pristine ZnO and MgO nanoparticle counterparts. The X-ray diffraction (XRD) analysis of the ZnO/MgO nanocomposite reveals the existence of two phases in a single matrix with no other phases. Fourier Transform Infrared (FTIR) spectroscopic analysis of the ZnO/MgO nanocomposite displays the characteristic stretching vibration of Zn-O, Mg-O, and Zn-O-Mg bonds. The bandgap value of the ZnO/MgO nanocomposite is about 3.43 eV, which lies in between the bandgap energies of the ZnO (3.26 eV) and MgO (5.35 eV) nanoparticles. The X-ray photoelectron spectroscopic (XPS) investigations confirm the existence and the chemical state of zinc, magnesium, and oxygen in the ZnO/MgO nanocomposite. Scanning electron microscopic images of the ZnO/MgO nanocomposite display a morphology of porous, uneven grains. The ZnO/MgO nanocomposite reveals better antibacterial activity with a zone of inhibition value of 26.6 mm against Staphylococcus epidermidis and 25.4 mm for Escherichia coli at 150 µg/mL concentration, respectively. Similarly, the nanocomposite exhibits a better DPPH free radical scavenging capacity, with 92.2 % inhibition at 850 µg/mL concentration. Further, the ZnO/MgO nanocomposite shows a maximum enzyme inhibitory activity of 82.1 % and 82.9 % against the α-amylase and α-glucosidase enzymes at 850 µg/mL concentration, respectively. Thus, the green-derived ZnO/MgO nanocomposite exhibits intriguing biological features, emphasizing that it continues to be explored as a potential biomedical material.


